İbrahi̇m Karayaylalı

513 total citations
38 papers, 281 citations indexed

About

İbrahi̇m Karayaylalı is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, İbrahi̇m Karayaylalı has authored 38 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Epidemiology. Recurrent topics in İbrahi̇m Karayaylalı's work include Dialysis and Renal Disease Management (11 papers), Parathyroid Disorders and Treatments (6 papers) and Renal Transplantation Outcomes and Treatments (4 papers). İbrahi̇m Karayaylalı is often cited by papers focused on Dialysis and Renal Disease Management (11 papers), Parathyroid Disorders and Treatments (6 papers) and Renal Transplantation Outcomes and Treatments (4 papers). İbrahi̇m Karayaylalı collaborates with scholars based in Türkiye, Italy and Ireland. İbrahi̇m Karayaylalı's co-authors include Mustafa Balal, Saime Paydaş, Semra Bozfakioǧlu, Tekin Akpolat, Çeti̇n Özener, Fehmi Akçiçek, Taner Çamsarı, Cengiz Utaş, Rezzan Ataman and Mahmut Yavuz and has published in prestigious journals such as Journal of Clinical Medicine, Archives of Pharmacal Research and Peritoneal Dialysis International.

In The Last Decade

İbrahi̇m Karayaylalı

35 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İbrahi̇m Karayaylalı Türkiye 10 150 51 46 43 39 38 281
Jacek A Pietrzyk Poland 10 164 1.1× 29 0.6× 52 1.1× 48 1.1× 56 1.4× 42 344
G Fellay Switzerland 11 176 1.2× 19 0.4× 63 1.4× 53 1.2× 40 1.0× 21 358
Peter J. Somerville Canada 11 158 1.1× 67 1.3× 36 0.8× 43 1.0× 29 0.7× 21 354
Hark Rım South Korea 11 126 0.8× 18 0.4× 55 1.2× 33 0.8× 29 0.7× 52 315
Enrique Luna Spain 13 177 1.2× 63 1.2× 68 1.5× 29 0.7× 37 0.9× 50 409
Konstantinos Leivaditis Greece 12 165 1.1× 17 0.3× 73 1.6× 25 0.6× 29 0.7× 32 413
Yujun Deng China 12 234 1.6× 27 0.5× 35 0.8× 21 0.5× 45 1.2× 21 403
Eyüp Külah Türkiye 12 141 0.9× 30 0.6× 95 2.1× 19 0.4× 92 2.4× 27 365
Garip Şahin Türkiye 10 64 0.4× 37 0.7× 41 0.9× 33 0.8× 35 0.9× 26 210
Roberto Palumbo Italy 11 62 0.4× 16 0.3× 61 1.3× 64 1.5× 34 0.9× 27 309

Countries citing papers authored by İbrahi̇m Karayaylalı

Since Specialization
Citations

This map shows the geographic impact of İbrahi̇m Karayaylalı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İbrahi̇m Karayaylalı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İbrahi̇m Karayaylalı more than expected).

Fields of papers citing papers by İbrahi̇m Karayaylalı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İbrahi̇m Karayaylalı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İbrahi̇m Karayaylalı. The network helps show where İbrahi̇m Karayaylalı may publish in the future.

Co-authorship network of co-authors of İbrahi̇m Karayaylalı

This figure shows the co-authorship network connecting the top 25 collaborators of İbrahi̇m Karayaylalı. A scholar is included among the top collaborators of İbrahi̇m Karayaylalı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İbrahi̇m Karayaylalı. İbrahi̇m Karayaylalı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benlidayı, İlke Coşkun, et al.. (2024). Central sensitization: its prevalence and impact on quality of life among hemodialyzed patients. Irish Journal of Medical Science (1971 -). 193(3). 1595–1602. 2 indexed citations
2.
Kaya, Bülent, et al.. (2024). Hemodialysis Experience After Kahramanmaraş Earthquake. Journal of Clinical Medicine. 13(21). 6610–6610. 2 indexed citations
3.
Paydaş, Saime, et al.. (2021). Wolfram (DIDMOAD) Sendromu: Olgu Sunumu. DergiPark (Istanbul University). 17(2). 232–235.
4.
Kaya, Bülent, et al.. (2019). Serum fibroblast growth factor 23 levels do not correlate with carotid intima-media thickness in patients with chronic kidney disease. Saudi Journal of Kidney Diseases and Transplantation. 30(5). 1010–1010. 2 indexed citations
5.
Duman, Neval, Abdullah Uyanık, Alaettin Ünsal, et al.. (2014). Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia. Clinical Kidney Journal. 7(5). 464–469. 4 indexed citations
6.
Özener, Çeti̇n, Hakkı Arikan, İbrahi̇m Karayaylalı, et al.. (2013). The impact of diabetes mellitus on peritoneal dialysis: the Turkey Multicenter Clinic Study. Renal Failure. 36(2). 149–153. 23 indexed citations
7.
Balal, Mustafa, et al.. (2006). Endoskopik Biyopside Transthyretin Amiloid Pozitifliği Olan Hipopotasemik Bir Olgu. Turkiye Klinikleri Tip Bilimleri Dergisi. 26(1). 90–92.
8.
Balal, Mustafa, et al.. (2005). Dipyridamole for renal phosphate leak in successfully renal transplanted hypophosphatemic patients. Clinical Nephrology. 63(2). 87–91. 10 indexed citations
9.
Balal, Mustafa, et al.. (2005). Loss of vision and renal function in a patient with miliary tuberculosis.. PubMed. 72(2). 124–6. 2 indexed citations
10.
Karayaylalı, İbrahi̇m, et al.. (2005). Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients?. Scandinavian Journal of Urology and Nephrology. 39(5). 405–409. 15 indexed citations
11.
Paydaş, Saime, et al.. (2005). Long-Term Comparative Results of C0and C2Monitoring of CyA in Renal Transplanted Patients. Renal Failure. 27(4). 409–413. 3 indexed citations
12.
Paydaş, Saime, et al.. (2005). Severe acute renal failure due to tubulointerstitial nephritis, pancreatitis, and hyperthyroidism in a patient during rifampicin therapy. Advances in Therapy. 22(3). 241–243. 11 indexed citations
13.
Balal, Mustafa, et al.. (2004). Other Glomerular Pathologies in Three Patients with Diabetes Mellitus. Renal Failure. 26(2). 185–188. 4 indexed citations
14.
Karayaylalı, İbrahi̇m, Şeyda Erdoğan, Mustafa Balal, et al.. (2004). Nonsynergistic effects of trimetazidine and selenium combination therapy on renal ischemic-reperfusion injury in rats. Advances in Therapy. 21(1). 47–60. 6 indexed citations
15.
Balal, Mustafa, et al.. (2004). Oxidative–Antioxidative System in Peripartum Acute Renal Failure and Preeclampsia‐Eclampsia. Renal Failure. 26(6). 625–632. 6 indexed citations
17.
Balal, Mustafa, et al.. (2003). Report of a renal transplanted patient with fibroadenoma occurring in a short time. Transplantation Proceedings. 35(4). 1408–1409. 4 indexed citations
18.
Balal, Mustafa, et al.. (2003). Use of immunostippressive drugs and lamivudine in a patient with nephrotic syndrome, severe renal failure, and HBV cirrhosis: Case report. Advances in Therapy. 20(4). 191–194. 2 indexed citations
19.
Karayaylalı, İbrahi̇m, et al.. (2003). Effects of trimetazidine and selenium on high-frequency fatigue in isolated rat diaphragm muscle. Advances in Therapy. 20(5). 261–269. 1 indexed citations
20.
Taşkapan, Hülya, Çeti̇n Özener, Kenan Ateş, et al.. (2000). The Rate, Risk Factors, and Outcome of Fungal Peritonitis in CAPD Patients: Experience in Turkey. Peritoneal Dialysis International. 20(3). 338–341. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026